2020-10-23

Patient good news! Stem cell therapy is safe and effective for treating osteoarthritis!

Extensive clinical research data, both domestically and internationally, has confirmed that stem cell therapy is safe and effective in treating knee osteoarthritis. Stem cell therapy significantly improves joint pain symptoms and functional impairments in patients with knee osteoarthritis, while also demonstrating promising long-term benefits, making it a treatment approach with vast potential. For the growing number of arthritis patients, stem cell therapy offers new hope for recovery. We look forward to even more robust research and groundbreaking advancements in cellular treatment technologies!

+

2020-10-23

Big news! Five Guangdong departments have jointly issued a document aiming to secure national approval for offering cutting-edge medical treatments—approved by regulatory authorities in developed countries or regions—within designated medical institutions across the nine mainland cities of the Greater Bay Area!

Support Shenzhen in becoming a global hub for biomedical innovation and development, with a focus on advancing high-performance medical devices, bioinformatics, and cell & gene therapies. Organize and implement specialized initiatives in areas such as precision medicine, stem cells, innovative drug discovery, cutting-edge medical equipment, and critical technologies and equipment for traditional Chinese medicine—strengthening the capabilities of pharmaceutical manufacturing, as well as medical instruments and device production.

+

2020-09-29

Is stem cell therapy effective for heart disease? The evidence is right here.

Today is World Heart Day—let’s join forces to learn about the latest advancements in stem cell research for treating heart disease!

+

2020-09-25

Big news! The Beijing Institute of Stem Cell and Regenerative Medicine officially established in Beijing.

Big news! The Beijing Institute of Stem Cell and Regenerative Medicine has been established in Beijing. The institute is a new R&D institution jointly built by the Beijing Municipal Government and the Chinese Academy of Sciences.

+

2020-09-22

Set in stone! Beijing and Anhui Pilot Free Trade Zones: Supporting the Launch of Cutting-Edge Clinical Medical Research Projects in Areas Like Immune Cells and Stem Cells

Breaking news! Policies related to stem cell and immune cell medical technologies in Beijing and Anhui Free Trade Zones have been officially released!

+

2020-09-21

Video included | Filmed over 3 years: Japanese director documents mother's entire journey into dementia

Alzheimer's disease is a degenerative disorder of the central nervous system, and growing research evidence demonstrates that stem cells show promising therapeutic potential in treating Alzheimer's.

+

2020-09-21

National Dental Health Day | Stem cells may become a new weapon in treating oral diseases

September 20, 2020, marked the 32nd National Dental Health Day. As basic and clinical research continue to advance, stem cells may soon emerge as a powerful new tool for treating oral diseases!

+

2020-09-09

Nanjing issues document: Establishing a Pilot Demonstration Zone for New Medicine and the Life Sciences Industry, and advancing pilot initiatives in stem-cell therapy.

The Action Plan explicitly states: Strengthen the development of the pilot demonstration zone. Leveraging the Nanjing Area of the Free Trade Pilot Zone, establish a pioneering demonstration zone for the new pharmaceuticals and life sciences industries, and actively seek support from the National Health Commission to kickstart pilot initiatives in stem-cell therapy.

+

2020-09-04

Medical and research institutions within Shenzhen's Qianhai-Shekou Free Trade Zone can carry out research and translational applications of cutting-edge technologies such as stem cells and immune cells, in accordance with relevant regulations.

The "Free Trade Zone Regulations" clearly state: Article 51: Medical and research institutions within the free trade zone may, based on their own technical capabilities and in accordance with relevant regulations, carry out research and translational applications of cutting-edge technologies such as stem cells, immune cells, gene therapy, as well as monoclonal antibody drugs and tissue engineering.

+
< 1...192021...31 >